Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Schierholz, A. Schwarzkopf, O. Denk, I. Fischer, M. Keller (Graefelfing, Aura an der Saale, Tuebingen, Germany). Antimicrobial properties of aerosolized liposomal cyclosporine (L-CsA) in lung transplantation patients – An in vitro study. Eur Respir J 2010; 36: Suppl. 54, 3489

Member's Comments

No comment yet.

Related content which might interest you: Assessment of lung deposition and pharmacokinetics in 12 lung transplanted patients after inhalation of a novel liposomal ciclosporin a (CsA) formulation by the eFlow electronic nebuliser Source: Eur Respir J 2007; 30: Suppl. 51, 29s Year: 2007 Pharmacokinetics and antibacterial activity of inhaled liposomal ciprofloxacin hydrochloride in healthy volunteers and in cystic fibrosis (CF) patients Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Tolerance of nebulised gentamicin in adult bronchiectasis – A single centre study Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Laninamivir’s prolonged intrapulmonary retention: Intrapulmonary pharmacokinetics (PK) and the intracellular disposition to support the long-lasting efficacy after an inhaled administration of its prodrug laninamivir octanoate (LO) Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies Source: Eur Respir J, 56 (4) 2000110; 10.1183/13993003.00110-2020 Year: 2020 A placebo-controlled study of liposomal amikacin for inhalation nebulized once daily in the treatment of bronchiectasis patients with chronic pseudomonas aeruginosa lung infection Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009 A multicompartmemt lung model predicts pulmonary pharmacokinetics of inhaled liposomal treprostinil (L606) in healthy volunteer Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Pegylated liposomal doxorubicin HCl (Caelyx) in combination with sandostatin LAR as salvage therapy in patients with small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 78s Year: 2005 Comparative study of therapeutic effects of combination chemotherapy including various doses of clarithromycin for pulmonary Mycobacterium avium complex disease Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 Late Breaking Abstract - Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 174s Year: 2007 Curcumin in combination with low-dose cyclosporine a in experimental airway transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 518s Year: 2007 Safety and efficacy of intravenous (IV) Fosfomycin in adult cystic fibrosis patients Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Single dose pharmacokinetics of C16TR for Inhalation (INS1009) vs treprostinil inhalation solution Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Effects of basiliximab and triple therapy on airway mucociliary clearance of rats Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 LSC 2012 abstract – The cell-penetrating P1pal-12 pepducin limits pulmonary fibrosis in the murine bleomycin model Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Immunomodulating activity of inhalations of ultra-low doses of alkylating drug melphalan for severe bronchial asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Amikacin (AMK) minimum inhibitory concentrations (MICs) and mutational resistance in patients with treatment-refractory nontuberculous mycobacteria (NTM) lung disease (LD) treated with liposomal amikacin for inhalation (LAI) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system] Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010